BLUE

bluebird bio Inc

Price:

0.61

USD

Volume:

6,688,624.00

United States | Biotechnology

-495.42 %

Upside

As of 2024-09-14, the Fair Value of bluebird bio Inc (BLUE) is -2.40 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.61 USD, the upside of bluebird bio Inc is -495.42%.

Note: valuation result may not be accurate due to the company's negative EPS.

0.61 USD

Stock Price

-2.40 USD

Fair Price

Peter Lynch's formula is:

BLUE Fair Value

= Earnings Growth Rate x TTM EPS
BLUE Fair Value

= 5.00 x -0.48
BLUE Fair Value

= -2.40
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |

Net income | -555.63 | -789.61 | -618.70 | -819.38 | -266.58 | -609.98 |

YoY growth | -65.54% | -42.11% | 21.64% | -32.44% | 67.47% | -10.20% |

Market Cap (mil) | 115.32 |

P/E | |

Forward P/E |

EPS | -0.48 |

Avg earnings growth rate | -10.20% |

TTM earnings | -91.20 |